Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gene Therapy 'Cassettes' Could Speed, Cheapen Manufacturing, Gottlieb Says

May 24 2018

• By Derrick Gingery

DNA detail background with selective focus

Related Content

FDA Highlights Advanced Drug Manufacturing Approaches In Budget Plan

Feb 13 2018

New CDER No. 2 May Impact FDA's Safety Monitoring Aspirations

Apr 18 2018

Orphan Drug Policy Changes To Be Considered Under US FDA's FY 2019 Budget Proposal

Apr 05 2018

Real-World Data Could Get Boost From Trial Replication Project

Apr 27 2018

Gottlieb On Gene Therapies: 'Very Seductive' To Think About Accelerated Approval Pathway

May 07 2018

Real World Evidence Benefits, Limits Explored In US FDA Demonstrations

Oct 30 2017

Gene Therapy Guidances From US FDA Coming In About 6 Weeks, Gottlieb Says

May 11 2018

Pipeline Watch: Phase III Readouts For Talazoparib, Ampion, Avatrombopag

Dec 18 2017

Pfizer Advances Duchenne Drug As It Prioritizes Gene Therapy

Apr 12 2018

Related Companies

BioMarin Pharmaceutical Inc.

Spark Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

uniQure N.V.

Baxalta Incorporated

Additional Topics

United States Regenerative Medicine Regulation FDA Blood & Coagulation Disorders BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window